Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-109-7 | CAS number: 13170-05-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-10-14 - 2009-10-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Principles of method if other than guideline:
- Based on the fact that acute oral LD50 of male and female mice were all greater than 5000 mg/kg, experimental groups were determined to be 5000 mg/kg, 2500 mg/kg, 1250 mg/kg, a negative control group (com oil, 20 m!/kg), and a positive control group (cyclophosphamide, 40 mg/kg).
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Bis[4-(tert-butyl)benzoato-O]hydroxyaluminium
- EC Number:
- 236-109-7
- EC Name:
- Bis[4-(tert-butyl)benzoato-O]hydroxyaluminium
- Cas Number:
- 13170-05-3
- Molecular formula:
- C22H27AlO5
- IUPAC Name:
- aluminum hydroxide bis(4-tert-butylbenzoate)
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At normal room temperature and humidity in the lightproof sample storeroom
Test animals
- Species:
- mouse
- Strain:
- other: KM mice
- Details on species / strain selection:
- Mouse is prior recommended for the mammalian erythrocyte micronucleus test according to " OECD Guidelines for the Testing of Chemicals (2004) " 474.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Shanghai SILAIKE Experimental Animal Co. Ltd. Animal Production Certification: SCXK (Hu) 2007-0005. Animal Usage Certification: SYXK (Hu) 2007-0008.
- Weight at study initiation: body weight between 25~30g,
- Fasting period before study: yes, 3-4h
- Housing: Animals were housed in the plastic cages (L46>- Diet (e.g. ad libitum): laboratory diet was provided by Suzhou Shuangshi Laboratory Animal Feed Science and Technology Ltd. (Certification: Su (E) Sishengzi (2002) 006)
- Water (e.g. ad libitum): Laboratory drinking water was freely for accessing during the test period.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 40-70%
- Photoperiod (hrs dark / hrs light): The room is illuminated with 12 hours artificial fluorescent light and 12 hours dark per day.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Sample preparation was following the dosage design to weigh the test sample of all groups. Then 5000mg, 2500mg and 1250mg of the test sample were weighed and corn oil was added to 20ml and mixed extensively to form the test sample.
- Details on exposure:
- The test sample of various doses was administered to the mice by double oral gavages (24h's interval). All mice were weighed and the gavage volume was 0.4ml/20g bw.Mice were divided randomly into 5 groups by body weight, 30 for each group, half of each sex. Experimental groups were divided as 5000 mg/kg, 2500 mg/kg, 1250 mg/kg (high dosage, middle dosage, and low dosage) and a negative control (corn oil, 20 ml/kg) and a positive control group (cyclophosphamide 40 mg/kg).
- Duration of treatment / exposure:
- 24h or 48h after single application
- Frequency of treatment:
- single application
- Post exposure period:
- 24h, 36h, 48h after the last gavage.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- Remarks:
- high dosage
- Dose / conc.:
- 2 500 mg/kg bw/day (nominal)
- Remarks:
- middle dosage
- Dose / conc.:
- 1 250 mg/kg bw/day (nominal)
- Remarks:
- low dosage
- No. of animals per sex per dose:
- 15 / sex / dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Positive control: cyclophosphamide 40mg/kg
Examinations
- Tissues and cell types examined:
- femur bone marrow erythrocytes
- Details of tissue and slide preparation:
- 10 mice per group, half of each sex, were executed by cervical dislocation at 24h, 36h, 48h after the last gavage. Femur marrow was fetched out and mixed with bovine serum. Slides were smeared, fixed and stained by Giemsa's solution.
Microscopic Observation: 2000 polychromatic erythrocytes (PCE) of each mouse were counted and the number of PCE containing micronucleus was recorded, and then rate of cell containing micronucleus was calculated as parts per thousand. As 200 polychromatic erythrocytes (PCE) were counted, normal chromatic erythrocytes (NCE) were also counted to obtain the value of PCE/RBC. - Evaluation criteria:
- ACCEPTABILITY OF ASSAY
A micronucleus test is considered acceptable if it meets the following criteria:
a) The positive control substance induced a statistically significant (WiIcoxon Rank Sum Test, two-sided test at P (0.05) increase in the frequency of micronucleated polychromatic erythrocytes.
b) The incidence of micronucleated polychromatic erythrocytes in the control animals should reasonably be within the laboratory historical control data range.
In this study 10 mice per group, half of each sex, were executed by cervical dislocation at 24h, 36h, 48h after last gavage. Femur marrow was fetched out. Observed under the microscope, 2000 polychromatic erythrocytes (PCE) of each mouse were counted and number of PCE containing micronucleus was recorded, and then rate of cell containing micronucleus was calculated as parts per thousands. As 200 polychromatic erythrocytes (PCE) were counted, normal chromatic erythrocytes (NCE) were also counted to obtain the value of PCE/RBC. - Statistics:
- Compared with the negative group, rate of cell containing micronucleus of the dosage groups was analyzed by Chi Square test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- Mammalian Erythrocyte Micronucleus Test of the test substance, Bis(4-(tert-butyl)benzoate-0) hydroxyaluminium (CAS No. 13170-05-3) was negative. The test substance is not considered to be mutagenic.
- Executive summary:
Bis(4-(tert-butyl)benzoate-0) hydroxyaluminium was tested in the Micronucleus Test in mice according to OECD 474 under GLP, to evaluate its genotoxic effect on erythrocytes in bone marrow.
Mice were divided randomly into 5 groups, 30 animals for each group, half of each sex. Experimental groups were determined to be 5000 mg/kg, 2500 mg/kg, 1250 mg/kg, a negative control group (com oil, 20 ml/kg), and a positive control group (cyclophosphamide, 40 mg/kg). The test sample of various doses, the positive control and the negative control were administered to the mice by double oral gavages (24h's interval). The gavage volume was 0.4 ml/20g bw. 10 mice per group, half of each sex, were executed by cervical dislocation at 24h, 36h, 48h after last gavage. The rate of cell containing micronucleus of the dosage groups was analyzed compared with the negative group.
Mammalian Erythrocyte Micronucleus Test of the test substance, Bis(4-(tert-butyl)benzoate-0) hydroxyaluminium (CAS No. 13170-05-3) was negative. The test substance is not considered to be mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.